[PR Newswire] - ROCKVILLE, Md., Feb. 26, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious infections and diseases, announced today ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment